ViiV Healthcare (United Kingdom)
Institution data
| Type | COMPANY (active) |
|---|---|
| Country | London, GB |
| Works | 17 |
| Researchers | 18 |
| Coverage | 2015 - 2026 |
| ROR | 01cc9yk21 |
| GRID | grid.476798.3 |
| OpenAlex | I4210103149 |
| Website | https://www.viivhealthcare.com |
| Also known as | ViiV Healthcare (United Kingdom) |
Implementation Journey with CAB LA for PrEP Among Men Who Have Sex with Men and Transgender Men
Exploring the Interest and Intention to Use Long-Acting Injectable PrEP (LAI-PrEP) Among Gay, Bisexual and Other Men Who Have Sex with Men (GBMSM) in the Netherlands
Preference for Long-Acting HIV Prevention Methods Among Transgender Women Vulnerable to HIV in Eastern and Southern United States
Patient-Reported Outcomes After Switching to a 2-Drug Regimen of Fixed-Dose Combination Dolutegravir/Lamivudine
Improvements in Patient-Reported Outcomes After 12 Months of Maintenance Therapy With Cabotegravir + Rilpivirine Long-Acting Compared With Bictegravir/Emtricitabine/Tenofovir Alafenamide in the Phase 3b Solar Study
Treatment challenges and health conditions among people living with HIV with or without substance use disorder in the Russian Federation
The Influence of Anticipated HIV Stigma on Health-related Behaviors, Self-rated Health, and Treatment Preferences Among People Living with HIV in East Asia
Utility and Impact of the Implementation of Same-Day, Self-administered Electronic Patient-Reported Outcomes Assessments in Routine HIV Care in two North American Clinics
Patient preferences and health state utilities associated with the treatment process of antiretroviral therapy for people living with HIV
Vulnerability Conditions in a Cohort of Men Who Have Sex with Men Who Engage in Chemsex in Barcelona City
Factors Associated with Resilience Among Older People Living with HIV
Factors Associated with Treatment Satisfaction Among People Living with HIV in Japan and Other Selected Countries
Physical, Emotional, and Psychosocial Challenges Associated with Daily Dosing of HIV Medications and Their Impact on Indicators of Quality of Life
Shared Decision Making Between Patients and Healthcare Providers and its Association with Favorable Health Outcomes Among People Living with HIV
Patient-Reported Outcomes in Atlas and FLAIR Participants on Long-Acting Regimens of Cabotegravir and Rilpivirine Over 48 Weeks
Expanding the Menu of HIV Prevention Options
Health-related quality of life in Parkinson’s
Implementation Journey with CAB LA for PrEP Among Men Who Have Sex with Men and Transgender Men
Exploring the Interest and Intention to Use Long-Acting Injectable PrEP (LAI-PrEP) Among Gay, Bisexual and Other Men Who Have Sex with Men (GBMSM) in the Netherlands
Preference for Long-Acting HIV Prevention Methods Among Transgender Women Vulnerable to HIV in Eastern and Southern United States
Patient-Reported Outcomes After Switching to a 2-Drug Regimen of Fixed-Dose Combination Dolutegravir/Lamivudine
Improvements in Patient-Reported Outcomes After 12 Months of Maintenance Therapy With Cabotegravir + Rilpivirine Long-Acting Compared With Bictegravir/Emtricitabine/Tenofovir Alafenamide in the Phase 3b Solar Study
Treatment challenges and health conditions among people living with HIV with or without substance use disorder in the Russian Federation
The Influence of Anticipated HIV Stigma on Health-related Behaviors, Self-rated Health, and Treatment Preferences Among People Living with HIV in East Asia
Utility and Impact of the Implementation of Same-Day, Self-administered Electronic Patient-Reported Outcomes Assessments in Routine HIV Care in two North American Clinics
Patient preferences and health state utilities associated with the treatment process of antiretroviral therapy for people living with HIV
Vulnerability Conditions in a Cohort of Men Who Have Sex with Men Who Engage in Chemsex in Barcelona City
Factors Associated with Resilience Among Older People Living with HIV
Factors Associated with Treatment Satisfaction Among People Living with HIV in Japan and Other Selected Countries
Physical, Emotional, and Psychosocial Challenges Associated with Daily Dosing of HIV Medications and Their Impact on Indicators of Quality of Life
Shared Decision Making Between Patients and Healthcare Providers and its Association with Favorable Health Outcomes Among People Living with HIV
Patient-Reported Outcomes in Atlas and FLAIR Participants on Long-Acting Regimens of Cabotegravir and Rilpivirine Over 48 Weeks
Expanding the Menu of HIV Prevention Options
Health-related quality of life in Parkinson’s
Health-related quality of life in Parkinson’s
Expanding the Menu of HIV Prevention Options
Physical, Emotional, and Psychosocial Challenges Associated with Daily Dosing of HIV Medications and Their Impact on Indicators of Quality of Life
Shared Decision Making Between Patients and Healthcare Providers and its Association with Favorable Health Outcomes Among People Living with HIV
Patient-Reported Outcomes in Atlas and FLAIR Participants on Long-Acting Regimens of Cabotegravir and Rilpivirine Over 48 Weeks
Factors Associated with Resilience Among Older People Living with HIV
Factors Associated with Treatment Satisfaction Among People Living with HIV in Japan and Other Selected Countries
Treatment challenges and health conditions among people living with HIV with or without substance use disorder in the Russian Federation
The Influence of Anticipated HIV Stigma on Health-related Behaviors, Self-rated Health, and Treatment Preferences Among People Living with HIV in East Asia
Utility and Impact of the Implementation of Same-Day, Self-administered Electronic Patient-Reported Outcomes Assessments in Routine HIV Care in two North American Clinics
Patient preferences and health state utilities associated with the treatment process of antiretroviral therapy for people living with HIV
Vulnerability Conditions in a Cohort of Men Who Have Sex with Men Who Engage in Chemsex in Barcelona City
Preference for Long-Acting HIV Prevention Methods Among Transgender Women Vulnerable to HIV in Eastern and Southern United States
Patient-Reported Outcomes After Switching to a 2-Drug Regimen of Fixed-Dose Combination Dolutegravir/Lamivudine
Improvements in Patient-Reported Outcomes After 12 Months of Maintenance Therapy With Cabotegravir + Rilpivirine Long-Acting Compared With Bictegravir/Emtricitabine/Tenofovir Alafenamide in the Phase 3b Solar Study
Implementation Journey with CAB LA for PrEP Among Men Who Have Sex with Men and Transgender Men
Exploring the Interest and Intention to Use Long-Acting Injectable PrEP (LAI-PrEP) Among Gay, Bisexual and Other Men Who Have Sex with Men (GBMSM) in the Netherlands
| ARTICLE | 17 |
|---|
| 2026 | 2 |
|---|---|
| 2024 | 3 |
| 2022 | 5 |
| 2021 | 2 |
| 2020 | 3 |
| 2017 | 1 |
| 2015 | 1 |